Now you can visualize and analyze complex 3D cell models – with Harmony 4.8 software

Video   Jun 01, 2018

 

The most physiologically relevant processes and insights are
happening in 3D. So see what you’re missing with the new capabilities of
Harmony® 4.8 software for imaging, analysis, and visualization of
complex 3D cell models. With Harmony 4.8, you can: • Accelerate 3D image
acquisition and analysis • Better understand spatial relationships •
Discover new perspectives not visible in 2D • Measure volume and
morphology in 3D

 
More Information
 
 
 

Recommended Videos

Study Shows HPV-vaccine Against Cervical Cancer is Working

Video

Girls in the first birth cohort to be offered and receive the HPV vaccine showed a lower degree of dysplasia which may eventually lead to cervical cancer than a birth cohort from 1983. This is the conclusion of a new study conducted by researchers at the University of Copenhagen, who have been the first to study the vaccine’s effect on the general population.

WATCH NOW

LC-MS/MS for Bioanalytical Peptide and Protein Quantification: MS Considerations

Video

Caitlin Dunning, Associate Scientist, discusses how to use mass spectrometry to develop sensitive, selective, and robust quantification methods for peptide and protein quantification, including: basic mass spectrometry considerations, MS tuning, and best practices for success.

WATCH NOW

Targeting Tumors: Challenges of Antibody-Drug Conjugates

Video

More than two dozen ADCs are currently being used in the clinic to treat diseases like Hodgkin's lymphoma and breast cancer, and researchers are developing many more. But it's taken decades to find the right combination of drug, antibody target and linker, and then make sure the right amount of ADC hits the tumor.

WATCH NOW

 

Comments | 0 ADD COMMENT

Like what you just watched? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy